• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias.共识文件:脊髓小脑共济失调中神经退行性变的病理机制。
Cerebellum. 2014 Apr;13(2):269-302. doi: 10.1007/s12311-013-0539-y.
2
The spinocerebellar ataxias.脊髓小脑性共济失调
J Neuroophthalmol. 2009 Sep;29(3):227-37. doi: 10.1097/WNO0b013e3181b416de.
3
Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias.脊髓小脑共济失调中神经退行性变的细胞和分子途径。
Cerebellum. 2010 Jun;9(2):148-66. doi: 10.1007/s12311-009-0144-2.
4
Molecular pathogenesis of spinocerebellar ataxias.脊髓小脑共济失调的分子发病机制。
Brain. 2006 Jun;129(Pt 6):1357-70. doi: 10.1093/brain/awl081. Epub 2006 Apr 13.
5
Autosomal-dominant cerebellar ataxias.常染色体显性遗传性小脑共济失调
Handb Clin Neurol. 2018;147:173-185. doi: 10.1016/B978-0-444-63233-3.00012-9.
6
Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.浦肯野细胞中紊乱的钙信号转导与脊髓小脑性共济失调 2 型(SCA2)和其他共济失调的发病机制。
Cerebellum. 2012 Sep;11(3):630-9. doi: 10.1007/s12311-010-0182-9.
7
Spinocerebellar ataxia: an update.脊髓小脑共济失调:更新。
J Neurol. 2019 Feb;266(2):533-544. doi: 10.1007/s00415-018-9076-4. Epub 2018 Oct 3.
8
The ever expanding spinocerebellar ataxias. Editorial.不断扩展的脊髓小脑共济失调。社论。
Cerebellum. 2012 Dec;11(4):821-7. doi: 10.1007/s12311-012-0376-4.
9
Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications.共识文件:脊髓小脑共济失调动物模型的优缺点及其临床意义
Cerebellum. 2022 Jun;21(3):452-481. doi: 10.1007/s12311-021-01311-1. Epub 2021 Aug 10.
10
Clinical Characteristics and Possible Drug Targets in Autosomal Dominant Spinocerebellar Ataxias.常染色体显性遗传性脊髓小脑共济失调的临床特征及可能的药物靶点
CNS Neurol Disord Drug Targets. 2019;18(4):279-293. doi: 10.2174/1871527318666190311155846.

引用本文的文献

1
Identifying Molecular Properties of Ataxin-2 Inhibitors for Spinocerebellar Ataxia Type 2 Utilizing High-Throughput Screening and Machine Learning.利用高通量筛选和机器学习确定2型脊髓小脑共济失调中ataxin-2抑制剂的分子特性
Biology (Basel). 2025 May 8;14(5):522. doi: 10.3390/biology14050522.
2
Roles of Nucleic Acids in Protein Folding, Aggregation, and Disease.核酸在蛋白质折叠、聚集和疾病中的作用。
ACS Chem Biol. 2024 Apr 19;19(4):809-823. doi: 10.1021/acschembio.3c00695. Epub 2024 Mar 13.
3
Novel genotype-phenotype correlations, differential cerebellar allele-specific methylation, and a common origin of the (ATTTC) insertion in spinocerebellar ataxia type 37.新型基因型-表型相关性、小脑等位基因特异性甲基化差异以及脊髓小脑共济失调37型中(ATTTC)插入序列的共同起源
Hum Genet. 2024 Mar;143(3):211-232. doi: 10.1007/s00439-024-02644-7. Epub 2024 Feb 23.
4
Spinocerebellar ataxia type 11 (SCA11): TTBK2 variants, functions and associated disease mechanisms.脊髓小脑性共济失调 11 型(SCA11): TTBK2 变异体、功能及相关疾病机制。
Cerebellum. 2024 Apr;23(2):678-687. doi: 10.1007/s12311-023-01540-6. Epub 2023 Mar 9.
5
Spinocerebellar Ataxia in a Hungarian Female Patient with a Novel Variant of Unknown Significance in the Gene.遗传性小脑共济失调患者的基因中出现一种新的意义不明变异
Int J Mol Sci. 2023 Jan 30;24(3):2617. doi: 10.3390/ijms24032617.
6
Mechanistic Insights and Potential Therapeutic Approaches in PolyQ Diseases via Autophagy.通过自噬对多聚谷氨酰胺疾病的机制性见解及潜在治疗方法
Biomedicines. 2023 Jan 9;11(1):162. doi: 10.3390/biomedicines11010162.
7
MDSN: A Module Detection Method for Identifying High-Order Epistatic Interactions.MDSN:一种用于识别高阶上位性相互作用的模块检测方法。
Genes (Basel). 2022 Dec 18;13(12):2403. doi: 10.3390/genes13122403.
8
The Clinical Concept of LTDpathy: Is Dysregulated LTD Responsible for Prodromal Cerebellar Symptoms?长时程抑制功能障碍(LTDpathy)的临床概念:长时程抑制失调是否导致小脑前驱症状?
Brain Sci. 2022 Feb 24;12(3):303. doi: 10.3390/brainsci12030303.
9
New spinocerebellar ataxia subtype caused by mutation triggering mitochondrial dysregulation (SCA49).由触发线粒体失调的突变引起的新的脊髓小脑共济失调亚型(SCA49)。
Brain Commun. 2022 Feb 10;4(2):fcac030. doi: 10.1093/braincomms/fcac030. eCollection 2022.
10
Toe Walking as the Initial Symptom of a Spinocerebellar Ataxia 13 in a Patient Presenting with a Mutation in the KCNC3 Gene.以足尖行走为首发症状的脊髓小脑共济失调13型患者伴有KCNC3基因突变
Glob Med Genet. 2021 Oct 19;9(1):51-53. doi: 10.1055/s-0041-1736483. eCollection 2022 Mar.

本文引用的文献

1
New subtype of spinocerebellar ataxia with altered vertical eye movements mapping to chromosome 1p32.具有改变的垂直眼球运动的新的脊髓小脑共济失调亚型,定位于 1p32 染色体。
JAMA Neurol. 2013 Jun;70(6):764-71. doi: 10.1001/jamaneurol.2013.2311.
2
A novel function of Ataxin-1 in the modulation of PP2A activity is dysregulated in the spinocerebellar ataxia type 1.Ataxin-1 在调节 PP2A 活性方面的新功能在脊髓小脑共济失调 1 型中失调。
Hum Mol Genet. 2013 Sep 1;22(17):3425-37. doi: 10.1093/hmg/ddt197. Epub 2013 Apr 29.
3
Paradoxical effects of repeat interruptions on spinocerebellar ataxia type 10 expansions and repeat instability.重复中断对脊髓小脑性共济失调 10 型扩展和重复不稳定性的矛盾影响。
Eur J Hum Genet. 2013 Nov;21(11):1272-6. doi: 10.1038/ejhg.2013.32. Epub 2013 Feb 27.
4
Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.特定基因型的萎缩进展模式比 SCA1、SCA3 和 SCA6 的临床衰退更敏感。
Brain. 2013 Mar;136(Pt 3):905-17. doi: 10.1093/brain/aws369. Epub 2013 Feb 18.
5
Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS.非传统翻译 C9ORF72 GGGGCC 扩展产生特定于 c9FTD/ALS 的不溶性多肽。
Neuron. 2013 Feb 20;77(4):639-46. doi: 10.1016/j.neuron.2013.02.004. Epub 2013 Feb 12.
6
Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19.KCnd3 钾通道基因突变导致 19 型脊髓小脑共济失调。
Ann Neurol. 2012 Dec;72(6):870-80. doi: 10.1002/ana.23700.
7
Mutations in KCND3 cause spinocerebellar ataxia type 22.KCND3 基因突变导致脊髓小脑共济失调 22 型。
Ann Neurol. 2012 Dec;72(6):859-69. doi: 10.1002/ana.23701.
8
PolyQ disease: misfiring of a developmental cell death program?多聚谷氨酰胺疾病:发育细胞死亡程序的故障?
Trends Cell Biol. 2013 Apr;23(4):168-74. doi: 10.1016/j.tcb.2012.11.003. Epub 2012 Dec 8.
9
Large-scale screen for modifiers of ataxin-3-derived polyglutamine-induced toxicity in Drosophila.在果蝇中大规模筛选 Ataxin-3 衍生的多聚谷氨酰胺诱导毒性的修饰物。
PLoS One. 2012;7(11):e47452. doi: 10.1371/journal.pone.0047452. Epub 2012 Nov 5.
10
Neuron-to-neuron transmission of α-synuclein fibrils through axonal transport.α-突触核蛋白纤维通过轴突运输在神经元间传递。
Ann Neurol. 2012 Oct;72(4):517-24. doi: 10.1002/ana.23747.

共识文件:脊髓小脑共济失调中神经退行性变的病理机制。

Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias.

机构信息

Health Sciences Research Institute Germans Trias i Pujol (IGTP), Ctra. de Can Ruti, Camí de les Escoles s/n, Badalona, Barcelona, Spain,

出版信息

Cerebellum. 2014 Apr;13(2):269-302. doi: 10.1007/s12311-013-0539-y.

DOI:10.1007/s12311-013-0539-y
PMID:24307138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3943639/
Abstract

Intensive scientific research devoted in the recent years to understand the molecular mechanisms or neurodegeneration in spinocerebellar ataxias (SCAs) are identifying new pathways and targets providing new insights and a better understanding of the molecular pathogenesis in these diseases. In this consensus manuscript, the authors discuss their current views on the identified molecular processes causing or modulating the neurodegenerative phenotype in spinocerebellar ataxias with the common opinion of translating the new knowledge acquired into candidate targets for therapy. The following topics are discussed: transcription dysregulation, protein aggregation, autophagy, ion channels, the role of mitochondria, RNA toxicity, modulators of neurodegeneration and current therapeutic approaches. Overall point of consensus includes the common vision of neurodegeneration in SCAs as a multifactorial, progressive and reversible process, at least in early stages. Specific points of consensus include the role of the dysregulation of protein folding, transcription, bioenergetics, calcium handling and eventual cell death with apoptotic features of neurons during SCA disease progression. Unresolved questions include how the dysregulation of these pathways triggers the onset of symptoms and mediates disease progression since this understanding may allow effective treatments of SCAs within the window of reversibility to prevent early neuronal damage. Common opinions also include the need for clinical detection of early neuronal dysfunction, for more basic research to decipher the early neurodegenerative process in SCAs in order to give rise to new concepts for treatment strategies and for the translation of the results to preclinical studies and, thereafter, in clinical practice.

摘要

近年来,大量科学研究致力于理解脊髓小脑共济失调(SCA)中的分子机制或神经退行性变,这些研究正在确定新的途径和靶点,为这些疾病的分子发病机制提供新的见解和更好的理解。在这份共识文件中,作者讨论了他们目前对导致或调节 SCA 神经退行性表型的已识别分子过程的看法,其共同观点是将获得的新知识转化为治疗的候选靶点。以下是讨论的主题:转录失调、蛋白质聚集、自噬、离子通道、线粒体的作用、RNA 毒性、神经退行性变的调节剂和当前的治疗方法。总体共识点包括 SCA 神经退行性变是一种多因素、进行性和可逆转的过程,至少在早期阶段是这样。具体的共识点包括蛋白质折叠、转录、生物能量学、钙处理和神经元凋亡特征的细胞死亡的失调在 SCA 疾病进展中的作用。未解决的问题包括这些途径的失调如何引发症状的发生以及介导疾病的进展,因为这种理解可能允许在可逆转的窗口期内对 SCA 进行有效的治疗,以防止早期的神经元损伤。共同的观点还包括需要临床检测早期神经元功能障碍,进行更多的基础研究以阐明 SCA 中的早期神经退行性过程,从而为治疗策略带来新的概念,并将结果转化为临床前研究,然后转化为临床实践。